Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Loading
Home›
Research›
People›
Michael G. Wells
AddedMar 31, 2024
UpdatedJun 28, 2026
Michael G. Wells

Michael G. Wells

Founder, Princeton Biopharma Capital Partners

Crunchbase

Michael G. Wells's Career

Princeton Biopharma Capital Partners
Princeton Biopharma Capital Partners

Bridgewater Township, NJ, US

Founder
PhotoSonix Medical
PhotoSonix Medical

Ambler, PA, US

Board Member· Board
Fidelis Pharmaceuticals
Fidelis Pharmaceuticals

North Brunswick, NJ, US

CEO· C-Suite · Management

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview
aVenture product preview
aVenture product preview

Michael G. Wells's Career

Princeton Biopharma Capital Partners
Princeton Biopharma Capital Partners
Investment Firm22010Bridgewater Township, NJ, US
Founder

Similar to Princeton Biopharma Capital Partners

Prysm CapitalPrysm CapitalPrinceton, NJ, USest. 2019Prysm CapitalPrinceton, NJ, US · est. 2019

Prysm Capital: A growth equity firm empowering innovative teams with integrity.

17
Amicus Capital PartnersAmicus Capital PartnersChicago, IL, USAmicus Capital PartnersChicago, IL, US

Healthcare investment firm specializing in equity capital for mid-market biotech and medical sectors.

7
Princeton CapitalPrinceton CapitalDallas, TX, USest. 2013Princeton CapitalDallas, TX, US · est. 2013

Princeton Capital Corp: An externally managed firm investing in debt and equity for income and capital growth.

1
Prudential Private CapitalPrudential Private CapitalChicago, IL, USest. 1925Prudential Private CapitalChicago, IL, US · est. 1925

Prudential Private Capital: A trusted, global capital provider for businesses, fostering enduring partnerships for growth.

271
PhotoSonix Medical
PhotoSonix Medical

Ambler, PA, US

Board Member· Board
Fidelis Pharmaceuticals
Fidelis Pharmaceuticals
Series A$5.1M62016North Brunswick, NJ, US
CEO· C-Suite · Management

Leadership at Fidelis Pharmaceuticals

Barry LevinsonBarry LevinsonFounder

Similar to Fidelis Pharmaceuticals

Wilmington PharmaceuticalsWilmington PharmaceuticalsWilmington, NC, USDrug Formulationsest. 2002Wilmington PharmaceuticalsWilmington, NC, US · est. 2002

Wilmington Pharmaceuticals develops and licenses fast-dissolve drug formulations for easy patient administration.

Series B · $1.3M1
Elite PharmaceuticalsElite PharmaceuticalsNorthvale, NJ, USPharmaceuticalsest. 1996Elite PharmaceuticalsNorthvale, NJ, US · est. 1996

Elite Pharmaceuticals innovates and manufactures controlled-release pharmaceuticals, specializing in pain management.

Public · $7.5M53
US Specialty FormulationsUS Specialty FormulationsBethlehem, PA, USPharmaceuticalsest. 2013US Specialty FormulationsBethlehem, PA, US · est. 2013

US Specialty Formulations produces FDA-approved sterile injectable pharmaceuticals for healthcare providers globally.

Angel · $75k14
Companion PharmaCompanion PharmaSt. Louis, MO, USAnimal Health, Pet Pharmaceuticalsest. 2012Companion PharmaSt. Louis, MO, US · est. 2012

Innovative animal health products for companion animals in St. Louis.

Angel · $110k6

Michael G. Wells's Co-Investors

Mikal C HardenMikal C HardenCo-invested · Fulton Angel · 2 dealsMax KanevskyMax KanevskyCo-invested · Fulton Angel · 2 dealsRobert CorratoRobert CorratoCo-invested · Fulton Angel · 2 dealsRobert CorratoRobert CorratoCo-invested · Naturaz Seed · 2 dealsRobert KeithRobert KeithCo-invested · Fulton Angel · 2 deals

People Similar to Michael G. Wells

Nugroho HerucahyonoNugroho HerucahyonoCo-Founder · BukalapakJay Geoffrey WacherJay Geoffrey WacherBoard Member · BukalapakWillix HalimWillix HalimCEO · BukalapakAchmad ZakyAchmad ZakyCo-Founder · BukalapakLau Eng BoonLau Eng BoonBoard Member · BukalapakSoemantri BrodjonegoroSoemantri BrodjonegoroBoard Member · BukalapakChi-hyung SongChi-hyung SongBoard Member · DunamuHaeil YiHaeil YiCo-Founder · DunamuRICHARD F SIMONETTIRICHARD F SIMONETTICEO · Fidelis Capital PartnersRobert McBrideRobert McBrideFounder · Felix BiotechnologySamuel WillcoxonSamuel WillcoxonFounder · Fidelis SeniorCareRick SimonettiRick SimonettiCo-Founder · Fidelis Capital PartnersRonald GoldRonald GoldBoard Member · NJ Bio